BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 15225830)

  • 1. Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D.
    Khan S; Ali A; Khan S; Bakillah A; Damanhouri G; Khan A; Makki A; AlAnsari I; Banu N
    Nutr Metab (Lond); 2018; 15():13. PubMed ID: 29449867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and GI cancers: shedding some light on dark diseases.
    Hargrove L; Francis T; Francis H
    Ann Transl Med; 2014 Jan; 2(1):9. PubMed ID: 25332985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GC Glu416Asp and Thr420Lys polymorphisms contribute to gastrointestinal cancer susceptibility in a Chinese population.
    Zhou L; Zhang X; Chen X; Liu L; Lu C; Tang X; Shi J; Li M; Zhou M; Zhang Z; Xiao L; Yang M
    Int J Clin Exp Med; 2012; 5(1):72-9. PubMed ID: 22328951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.
    Garay E; Donnelly R; Wang X; Studzinski GP
    J Cell Physiol; 2007 Dec; 213(3):816-25. PubMed ID: 17520689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma.
    Yu ZJ; Yu JW; Cai W; Yuan HX; Li XY; Yuan Y; Chen JP; Wu XY; Yao DF
    World J Gastroenterol; 2005 Sep; 11(33):5221-5. PubMed ID: 16127757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic intra-arterial injection of lipiodol-1,25-dihydroxyvitamin D3 for hepatocellular carcinoma in rats.
    Jourdan JL; Akhter J; Bowrey P; Pourgholami M; Morris DL
    Anticancer Res; 2000; 20(4):2739-44. PubMed ID: 10953352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of lipiodol and medium chain triglyceride as delivery agents for hepatic arterial administration of 1, 25-dihydroxyvitamin D3--a potential new treatment for hepatocellular carcinoma.
    Finlay IG; Stewart GJ; Pourgholami MH; Akhter J; Morris DL
    Anticancer Res; 2000; 20(4):2705-9. PubMed ID: 10953347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25-dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferative effect in the human hepatoblastoma cell line HepG2.
    Pourgholami MH; Akhter J; Finlay IG; Morris DL
    Anticancer Res; 2000; 20(2A):723-7. PubMed ID: 10810346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic intra-arterial injection of 1,25-dihydroxyvitamin D3 in lipiodol: Pilot study in patients with hepatocellular carcinoma.
    Morris DL; Jourdan JL; Finlay I; Gruenberger T; The MP; Pourgholami MH
    Int J Oncol; 2002 Oct; 21(4):901-6. PubMed ID: 12239633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.
    Ghous Z; Akhter J; Pourgholami MH; Morris DL
    Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,25-Dihydroxyvitamin D3 in lipiodol for the treatment of hepatocellular carcinoma: cellular, animal and clinical studies.
    Pourgholami MH; Morris DL
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):513-8. PubMed ID: 15225830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
    Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
    Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.